Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03335163 · ClinicalTrials.gov registry record · Phase 1
The Effect of Topiramate on Etonogestrel Concentrations in Contraceptive Implant Users
A Phase 1 study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 1
- Development phase
- 48
- Enrollment target
NCT03335163 is a Phase 1 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 48 participants.
The verdict
NCT03335163, a Phase 1 study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 48 participants
- Enrollment target
Study Summary
A prospective, non-inferiority study to evaluate the pharmacokinetic effect of topiramate on serum Etonogestrel (ENG) levels in contraceptive implant users.
Interventions
- DRUG Topiramate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2018-03-15 |
| Est. Completion | 2021-04-22 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03335163
The ClinicalTrials.gov registry entry for NCT03335163 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Topiramate is the first listed.
NCT03335163 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03335163 about?
NCT03335163 is a clinical study titled "The Effect of Topiramate on Etonogestrel Concentrations in Contraceptive Implant Users". A prospective, non-inferiority study to evaluate the pharmacokinetic effect of topiramate on serum Etonogestrel (ENG) levels in contraceptive implant users.
What is the current status of trial NCT03335163?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 48 participants. The study started on 2018-03-15. Estimated completion is 2021-04-22.
What interventions are being tested in trial NCT03335163?
The interventions under investigation include: Topiramate (DRUG).
Who is sponsoring clinical trial NCT03335163?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.